Tomoko Hirohashi
- Oncology top 1%
- Pediatrics, Perinatology and Child Health top 1%
- Surgery top 5%
- Molecular Biology
- Pharmacology top 1%
- Co-authors
- Yuichi SugiyamaHiroshi SuzukiKazuhiko KumeKousei ItoHajime TakikawaTakao ShimizuHirotoshi SuzukiCharles A. Tyson
- Topics
- Drug Transport and Resistance Mechanisms (13 papers)Pediatric Hepatobiliary Diseases and Treatments (7 papers)Pharmacological Effects and Toxicity Studies (6 papers)
- Partner nations
- JapanUnited StatesItaly
In The Last Decade
Tomoko Hirohashi
28 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 99
- Oncology 1.9k
- Pediatrics, Perinatology and Child Health 986
- Surgery 628
- Molecular Biology 413
- Pharmacology 396
Countries citing papers authored by Tomoko Hirohashi
This map shows the geographic impact of Tomoko Hirohashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Hirohashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Hirohashi more than expected).
Fields of papers citing papers by Tomoko Hirohashi
This network shows the impact of papers produced by Tomoko Hirohashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Hirohashi. The network helps show where Tomoko Hirohashi may publish in the future.
Co-authorship network of co-authors of Tomoko Hirohashi
This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Hirohashi. A scholar is included among the top collaborators of Tomoko Hirohashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Hirohashi. Tomoko Hirohashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancer. | 6 |
| 4 | 13 | |
| 5 | 10 | |
| 6 | 27 | |
| 7 | 79 | |
| 8 | 125 | |
| 9 | 3 | |
| 10 | 106 | |
| 11 | 264 | |
| 12 | 203 | |
| 13 | 126 | |
| 14 | 171 | |
| 15 | 54 | |
| 16 | 287 | |
| 17 | 173 | |
| 18 | 99 | |
| 19 | 251 | |
| 20 | Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. | 172 |
About Tomoko Hirohashi
Tomoko Hirohashi is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience, having authored 29 papers that have together received 2.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (13 papers), Pediatric Hepatobiliary Diseases and Treatments (7 papers) and Pharmacological Effects and Toxicity Studies (6 papers). The work is most often cited by research in Oncology (1.9k citations), Pediatrics, Perinatology and Child Health (986 citations) and Pharmacology (396 citations). Tomoko Hirohashi has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Yuichi Sugiyama, Hiroshi Suzuki, Kazuhiko Kume, Kousei Ito, Hajime Takikawa, Takao Shimizu, Yuichi Sugiyama, Hirotoshi Suzuki, Hiroshi Suzuki and Charles A. Tyson. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.